JP2009506753A5 - - Google Patents

Download PDF

Info

Publication number
JP2009506753A5
JP2009506753A5 JP2008512901A JP2008512901A JP2009506753A5 JP 2009506753 A5 JP2009506753 A5 JP 2009506753A5 JP 2008512901 A JP2008512901 A JP 2008512901A JP 2008512901 A JP2008512901 A JP 2008512901A JP 2009506753 A5 JP2009506753 A5 JP 2009506753A5
Authority
JP
Japan
Prior art keywords
tcr
seq
sequence
vygfvracl
hla
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008512901A
Other languages
English (en)
Japanese (ja)
Other versions
JP5149789B2 (ja
JP2009506753A (ja
Filing date
Publication date
Priority claimed from PCT/GB2005/002078 external-priority patent/WO2005116646A1/en
Priority claimed from GBGB0524477.7A external-priority patent/GB0524477D0/en
Application filed filed Critical
Priority claimed from PCT/GB2006/001857 external-priority patent/WO2006125962A2/en
Publication of JP2009506753A publication Critical patent/JP2009506753A/ja
Publication of JP2009506753A5 publication Critical patent/JP2009506753A5/ja
Application granted granted Critical
Publication of JP5149789B2 publication Critical patent/JP5149789B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008512901A 2005-05-25 2006-05-19 Vygfvracl−hla−a24に特異的に結合するt細胞レセプター Expired - Fee Related JP5149789B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/GB2005/002078 WO2005116646A1 (en) 2004-05-26 2005-05-25 Method for the identification of a polypeptide which binds to a given pmhc complex
GBPCT/GB2005/002078 2005-05-25
GB0524477.7 2005-11-30
GBGB0524477.7A GB0524477D0 (en) 2005-11-30 2005-11-30 Isolated T cell receptors which specifically bind to vygfvracl-hla-24
PCT/GB2006/001857 WO2006125962A2 (en) 2005-05-25 2006-05-19 T cell receptors which specifically bind to vygfvracl-hla-a24

Publications (3)

Publication Number Publication Date
JP2009506753A JP2009506753A (ja) 2009-02-19
JP2009506753A5 true JP2009506753A5 (https=) 2009-07-02
JP5149789B2 JP5149789B2 (ja) 2013-02-20

Family

ID=35685841

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008512901A Expired - Fee Related JP5149789B2 (ja) 2005-05-25 2006-05-19 Vygfvracl−hla−a24に特異的に結合するt細胞レセプター

Country Status (8)

Country Link
US (1) US8017730B2 (https=)
EP (1) EP1885754B1 (https=)
JP (1) JP5149789B2 (https=)
CN (1) CN101389652B (https=)
AT (1) ATE497976T1 (https=)
DE (1) DE602006020037D1 (https=)
ES (1) ES2360598T3 (https=)
GB (1) GB0524477D0 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7994298B2 (en) 2004-09-24 2011-08-09 Trustees Of Dartmouth College Chimeric NK receptor and methods for treating cancer
WO2011059836A2 (en) 2009-10-29 2011-05-19 Trustees Of Dartmouth College T cell receptor-deficient t cell compositions
US12492376B2 (en) 2009-10-29 2025-12-09 The Trustees Of Dartmouth College T-cell receptor-deficient T cell compositions
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
WO2013033626A2 (en) 2011-08-31 2013-03-07 Trustees Of Dartmouth College Nkp30 receptor targeted therapeutics
WO2013169691A1 (en) 2012-05-07 2013-11-14 Trustees Of Dartmouth College Anti-b7-h6 antibody, fusion proteins, and methods of using the same
KR102499753B1 (ko) 2012-07-27 2023-02-16 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 T 세포 수용체 조작
EP3404111A1 (en) * 2013-03-13 2018-11-21 Health Research, Inc. Compositions and methods for use of recombinant t cell receptors for direct recognition of tumor antigen
KR102415259B1 (ko) 2013-11-22 2022-06-30 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 조작된 고-친화도의 인간 t 세포 수용체
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
GB201516277D0 (en) * 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR libraries
WO2017076308A1 (zh) * 2015-11-04 2017-05-11 广州市香雪制药股份有限公司 识别ny-eso-1抗原短肽的tcr
CN107987155A (zh) * 2016-10-27 2018-05-04 中国科学院广州生物医药与健康研究院 识别sage1抗原短肽的t细胞受体
CN109251243B (zh) * 2017-07-13 2021-10-19 中国科学院广州生物医药与健康研究院 一种识别sage1抗原的t细胞受体及编码该受体的核酸
WO2019069125A1 (en) 2017-10-06 2019-04-11 Oslo Universitetssykehus Hf CHIMERIC ANTIGEN RECEPTORS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759243B2 (en) * 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
IL160359A0 (en) * 2001-08-31 2004-07-25 Avidex Ltd Soluble t cell receptor
PT1558643E (pt) * 2002-11-09 2009-08-24 Immunocore Ltd Apresentação de um receptor das células t
ATE430164T1 (de) * 2004-05-26 2009-05-15 Immunocore Ltd Hochaffine telomerase-t-zellen-rezeptoren
GB0427585D0 (en) * 2004-12-16 2005-01-19 Avidex Ltd Assay

Similar Documents

Publication Publication Date Title
JP2009506753A5 (https=)
JP2008535826A5 (https=)
AU2024287134A1 (en) Multi-chain chimeric polypeptides and uses there
CA3139051A1 (en) Multispecific proteins
Wood et al. Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding
CA2952095C (en) Use of melanocortins to treat insulin sensitivity
DK1765860T3 (da) Ny-ESO-T.cellereceptor med höj affinitet
RU2016101711A (ru) Высокостабильный т-клеточный рецептор и способ его получения и применения
JP2008545426A5 (https=)
JP2018515088A5 (https=)
RU2017114414A (ru) НОВЫЕ АНТАГОНИСТЫ α4β7 НА ОСНОВЕ МОНОМЕРНЫХ И ДИМЕРНЫХ ПЕПТИДОВ
SA110310492B1 (ar) بيبتيدات خاصة بمستقبلات الميلانو كورتين
HRP20190689T1 (hr) Muteini suznog lipokalina koji vežu il-4r alfa
HRP20220865T1 (hr) T stanični receptori
JP2017530090A5 (https=)
IL199263A (en) Glucagon peptide with enhanced solubility, pharmaceutical composition containing it and its uses for drug preparation
JP2012508164A5 (https=)
Boules et al. Bioactive analogs of neurotensin: focus on CNS effects
Yamamoto et al. Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for δ/μ opioid receptor agonists and neurokinin-1 receptor antagonists
HRP20240135T1 (hr) Fgf21 mutanti i njihove upotrebe
JP2013518115A5 (https=)
EA201270135A1 (ru) T-клеточные рецепторы
JP2009286793A5 (https=)
JP2021526795A5 (https=)
CA3082794A1 (en) Methods for treatment of bile acid-related disorders